eRAM
encyclopedia of Rare Disease Annotation for Precision Medicine
| Disease | cystic fibrosis |
| Symptom | C0009450|infection |
| Sentences | 124 |
| PubMedID- 21545738 | M. abscessus infection was associated with cystic fibrosis and m. xenopi infection was associated with male gender. |
| PubMedID- 21494150 | Purpose of review: lung disease in cystic fibrosis (cf) results from chronic airway infection and inflammation leading to progressive bronchiectasis and respiratory failure. |
| PubMedID- 24925006 | Eradication strategy for persistent methicillin-resistant staphylococcus aureus infection in individuals with cystic fibrosis--the pmep trial: study protocol for a randomized controlled trial. |
| PubMedID- 20097812 | The ubiquitous opportunistic human pathogen pseudomonas aeruginosa secretes a viscous extracellular polysaccharide, called alginate, as a virulence factor during chronic infection of patients with cystic fibrosis. |
| PubMedID- 20729233 | Background: initial pulmonary pseudomonas aeruginosa infection in patients with cystic fibrosis (cf) is currently treated with intensive antibiotic therapy. |
| PubMedID- 20019078 | During the chronic lung infection of patients with cystic fibrosis (cf), pseudomonas aeruginosa can survive for long periods due to adaptive evolution mediated by genetic variation. |
| PubMedID- 21893650 | Comparative efficacy and safety of 4 randomized regimens to treat early pseudomonas aeruginosa infection in children with cystic fibrosis. |
| PubMedID- 20211000 | Nocardia farcinica lung infection in a patient with cystic fibrosis: a case report. |
| PubMedID- 22916223 | Defective mucus secretion may result in failure of host defense against pathogens, which in turn could be the underlying pathogenesis of airway infection in patients with cystic fibrosis (cf) 2. |
| PubMedID- 22708424 | Results: survival medians for 1991-2000 and 2001-2010 was 25.7 and 35.1 years, respectively in the group of mucoviscidosis patients with staphylococcus aureus infection survival was significantly higher than in those infected with gram-negative microflora. |
| PubMedID- 22785192 | The genus achromobacter currently is comprised of seven species, including achromobacter xylosoxidans, an opportunistic and nosocomial pathogen that displays broad-spectrum antimicrobial resistance and is recognized as causing chronic respiratory tract infection in persons with cystic fibrosis (cf). |
| PubMedID- 20218338 | Identification of possible mechanisms of lung infection in patients with cystic fibrosis will allow to develop evidence-based system of prevention of infectious complications in these patients. |
| PubMedID- 21067323 | Previously considered to have minimal inherent virulence owing to their commensal ability, the last decade has heralded an increasing recognition of candida infection among patients with cystic fibrosis. |
| PubMedID- 25709717 | Similarly, emond and co-workers chose samples for exome sequencing based on the extremes of the first time to pseudomonas infection in individuals with cystic fibrosis. |
| PubMedID- 22081229 | The identification of 17 b. dolosa genes that underwent selective pressure during infection in subjects with cystic fibrosis highlights key pathways involved in pathogenesis and may suggest new therapeutic targets for this and other lung infections. |
| PubMedID- 20238363 | Neuraminidase inhibitors for the treatment of influenza infection in people with cystic fibrosis. |
| PubMedID- 25815200 | 2010 dabigatranprevention of stroke or systemic embolism in patients with non-valvular atrial fibrillationboehringer ingelheim pty ltdpbsfinancially-basedpublic summary document atomoxetine hydrochlorideadhd diagnosed between the ages of 6 and 18 yearseli lilly australia pty ltdpbsfinancially-basedpublic summary document fingolimodrrmsnovartis pharmaceuticals australia pty ltdpbsfinancially-based; outcome-basedpublic summary document cinacalcet hydrochlorideend stage renal disease receiving dialysis who have uncontrolled secondary hyperparathyroidismamgen australia pty ltdpbsfinancially-basedpbs schedule , public summary document clostridium botulinum type a toxin-haemagglutinin complexsevere spasticity of the upper limb in adults following a stroke, as an adjunct to physical therapyipsen pty ltdpbsfinancially-basedpublic summary document fentanyl citratefentanyl lozenges for the treatment of breakthrough painorphan australia pty ltdpbsfinancially-basedpublic summary document natalizumabrrmsbiogen idec australia pty ltdpbsfinancially-basedpublic summary document paliperidoneschizophreniajanssen-cilag pty ltdpbsfinancially-basedpublic summary document botulinum toxin type a purified neurotoxin complexmoderate to severe spasticity of the upper limb in adults following a stroke as an adjunct to physical therapyallergan australia pty ltdpbsfinancially-basedpublic summary document tenofovir disoproxil fumaratetreatment of chronic hepatitis bgilead sciences pty ltdpbsfinancially-basedpublic summary document pramipexole hydrochlorideidiopathic parkinson diseaseboehringer ingelheim pty ltdpbsfinancially-basedpublic summary document tobramycinpseudomonas aeruginosa respiratory infection in a patient with cystic fibrosisnovartis pharmaceuticals australia pty ltdpbsfinancially-basedpublic summary document ticagreloracs, mi, or unstable anginaastrazeneca pty ltdpbsfinancially-basedpublic summary document pregabalinneuropathic painpfizer australia pty ltdpbsfinancially-basedpublic summary document rivaroxabanacute symptomatic dvtbayer australia ltdpbsfinancially-basedpublic summary document aztreonampseudomonas aeruginosa infection in patients with cystic fibrosisgilead sciences pty ltdpbsfinancially-basedpublic summary document crinone (progesterone gel)supplement progesterone in women who have luteal phase defectmerck seronopbsfinancially-basedrobertson et al. |
| PubMedID- 25705428 | In the last decade, many studies published the use of colistin in the treatment of lung infection in patients without cystic fibrosis, with conflicting results. |
| PubMedID- 24091166 | Background: inhaled tobramycin therapy has been shown to be efficacious in clinical trials for the eradication of initial pseudomonas aeruginosa infection in children with cystic fibrosis (cf). |
| PubMedID- 23375733 | Prevalence of helicobacter pylori infection in patients with cystic fibrosis. |
| PubMedID- 25027419 | Rationale: pseudomonas aeruginosa (pa) serology could potentially be a useful adjunct to respiratory culture methods for the detection of initial or early pa infection in patients with cystic fibrosis (cf). |
| PubMedID- 23984384 | However, the most serious medical problem caused by p. aeruginosa is lung infection associated with cystic fibrosis 3. |
| PubMedID- 24696136 | However, the role of antibiotic treatment of stenotrophomonas maltophilia infection in people with cystic fibrosis is still unclear. |
| PubMedID- 22336832 | Palivizumab for prophylaxis against respiratory syncytial virus infection in children with cystic fibrosis. |
| PubMedID- 25470304 | Antibiotic treatment for nontuberculous mycobacteria lung infection in people with cystic fibrosis. |
| PubMedID- 20678316 | We report an outbreak of corynebacterium pseudodiphtheriticum infection in children with cystic fibrosis (cf). |
| PubMedID- 22940004 | There is clear evidence some viral infections are associated with cystic fibrosis that dual infection is more likely to produce symptoms, and mechanisms of viral-induced exacerbation should be elucidated. |
| PubMedID- 20185551 | A coordinated approach has been used to measure the fitness of bcc bacteria isolated from cystic fibrosis (cf) patients with chronic bcc infection using methods relevant to bcc growth and survival conditions. |
| PubMedID- 20146956 | Nocardia farcinica infection in a patient with cystic fibrosis. |
| PubMedID- 22762867 | Comparison of two treatment regimens for eradication of pseudomonas aeruginosa infection in children with cystic fibrosis. |
| PubMedID- 22592739 | However, the role of antibiotic treatment of stenotrophomonas maltophilia infection in people with cystic fibrosis is still unclear. |
| PubMedID- 20942647 | Aeruginosa cell counts in a rat lung infection model and in patients with cystic fibrosis. |
| PubMedID- 24510624 | Colistimethate sodium dry powder for inhalation: a review of its use in the treatment of chronic pseudomonas aeruginosa infection in patients with cystic fibrosis. |
| PubMedID- 23737087 | Palivizumab for prophylaxis against respiratory syncytial virus infection in children with cystic fibrosis. |
| PubMedID- 24515341 | Objectives: to assess the effects of neuraminidase inhibitors for the treatment of influenza infection in people with cystic fibrosis. |
| PubMedID- 23066486 | Emergence of pseudomonas aeruginosa cross-infection in children with cystic fibrosis attending an iranian referral pediatric center. |
| PubMedID- 25146522 | Aeruginosa infection in patients with cystic fibrosis. |
| PubMedID- 24851825 | Palivizumab for prophylaxis against respiratory syncytial virus infection in children with cystic fibrosis. |
| PubMedID- 22717532 | Objective: to examine the incidence of recurrent clostridium difficile infection in patients with cystic fibrosis (cf), including patients who had undergone lung transplantation, and review clinical findings in hospitalized patients with c. |
| PubMedID- 20166098 | Palivizumab for prophylaxis against respiratory syncytial virus infection in children with cystic fibrosis. |
| PubMedID- 26003071 | Aeruginosa in order to evaluate the epidemiological situation of this infection in patients with cystic fibrosis attending our centre; 2. |
| PubMedID- 24064077 | Bacterial sinusitis can be a focus for initial lung colonisation and chronic lung infection in patients with cystic fibrosis. |
| PubMedID- 20951086 | Murine models of acute and chronic lung infection with cystic fibrosis pathogens. |
| PubMedID- 25068317 | Pseudomonas aeruginosa can grow to very high-cell-density (hcd) during infection of the cystic fibrosis (cf) lung. |
| PubMedID- 22119262 | Aims: to know the characteristics and prevalence of non-tuberculous mycobacterial infection infection in patients with non-cystic fibrosis bronchiectasis. |
| PubMedID- 25741986 | Selection criteria: randomized controlled trials of antibiotic therapy based on biofilm antimicrobial susceptibility testing compared to antibiotic therapy based on conventional antimicrobial susceptibility testing in the treatment of pseudomonas aeruginosa pulmonary infection in people with cystic fibrosis. |
| PubMedID- 21189901 | Results reveal that they have a potential role as a novel antimicrobial agent for the treatment of infection due to cystic fibrosis (cf)-related opportunistic pathogens. |
| PubMedID- 24648553 | Trichosporon mycotoxinivorans infection in patients with cystic fibrosis. |
| PubMedID- 25241695 | Human rhinovirus infection in children with cystic fibrosis. |
| PubMedID- 22905192 | It is a leading cause of acute pneumonia in hospitalized patients and is responsible for chronic lung infection in patients with cystic fibrosis. |